Pelosi bill aims to negotiate Medicare prices on top 250 drugs, penalize manufacturers that don’t comply
The bill, unlikely to gain any Republican support, is a political marker for Democrats eager to outflank President Trump on high drug prices, which is a top voter concern.
View original article
Contributor: Yasmeen Abutaleb
